Testing effectiveness (Phase 2)Looking for participantsNCT07223424
What this trial is testing
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
Who this might be right for
Renal Cell CarcinomaNon Small Cell Lung CancerMelanoma+9 more
Diwakar Davar 880